Lale White's most recent trade in Cardiff Oncology Inc was a trade of 40,565 Stock Options done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiff Oncology Inc | Lale White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 40,565 | 158,681 | - | - | Stock Options | |
| Cardiff Oncology Inc | Lale White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 29,700 | 146,974 | - | - | Stock Options | |
| Cardiff Oncology Inc | Lale White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 27,700 | 117,274 | - | - | Stock Options | |
| Cardiff Oncology Inc | Lale White | Director | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 19 Sep 2022 | 15,000 | 113,788 (1%) | 0% | 1.6 | 24,525 | Common Stock |
| Cardiff Oncology Inc | Lale White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 28,858 | 60,716 | - | - | Stock Options | |
| Cardiff Oncology Inc | Lale White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.60 per share. | 05 Jul 2022 | 28,858 | 98,788 (0%) | 0% | 2.6 | 75,031 | Common Stock |
| Cardiff Oncology Inc | Lale White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 26,800 | 89,574 | - | - | Stock Options |